Selling and Marketing Expense of HERON THERAPEUTICS, INC. /DE/ from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly and annual Selling and Marketing Expense in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • HERON THERAPEUTICS, INC. /DE/ Selling and Marketing Expense for the quarter ending 31 Dec 2025 was $12,233,000, a 11% increase year-over-year.
  • HERON THERAPEUTICS, INC. /DE/ Selling and Marketing Expense for the twelve months ending 31 Dec 2025 was $49,061,000, a 4.2% increase year-over-year.
  • HERON THERAPEUTICS, INC. /DE/ annual Selling and Marketing Expense for 2025 was $49,061,000, a 4.2% increase from 2024.
  • HERON THERAPEUTICS, INC. /DE/ annual Selling and Marketing Expense for 2024 was $47,085,000, a 30% decline from 2023.
  • HERON THERAPEUTICS, INC. /DE/ annual Selling and Marketing Expense for 2023 was $67,643,000, a 18% decline from 2022.
Source SEC data
View on sec.gov
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Change (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $49,061,000 $12,233,000 +$1,176,000 +11% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $47,885,000 $12,942,000 +$1,970,000 +18% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $45,915,000 $11,575,000 -$2,039,000 -15% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $47,954,000 $12,311,000 +$869,000 +7.6% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $47,085,000 $11,057,000 -$1,271,000 -10% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $48,356,000 $10,972,000 -$1,984,000 -15% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $50,340,000 $13,614,000 -$7,591,000 -36% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 $57,931,000 $11,442,000 -$9,712,000 -46% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 $67,643,000 $12,328,000 -$5,447,000 -31% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $73,090,000 $12,956,000 -$5,422,000 -30% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $78,512,000 $21,205,000 -$1,733,000 -7.6% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $80,245,000 $21,154,000 -$2,268,000 -9.7% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $82,513,000 $17,775,000 -$6,712,000 -27% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $89,225,000 $18,378,000 -$6,828,000 -27% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $96,053,000 $22,938,000 +$688,000 +3.1% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $95,365,000 $23,422,000 +$8,186,000 +54% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $87,179,000 $24,487,000 +$8,934,000 +57% 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $78,245,000 $25,206,000 +$12,691,000 +101% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $65,554,000 $22,250,000 +$6,661,000 +43% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $58,893,000 $15,236,000 -$4,960,000 -25% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $63,853,000 $15,553,000 -$4,867,000 -24% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2021 2020 FY
Q3 2020 $68,720,000 $12,515,000 -$4,462,000 -26% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 $73,182,000 $15,589,000 -$8,058,000 -34% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $81,240,000 $20,196,000 -$8,524,000 -30% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q4 2019 $89,764,000 $20,420,000 +$463,000 +2.3% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $89,301,000 $16,977,000 +$696,000 +4.3% 01 Jul 2019 30 Sep 2019 10-K 24 Feb 2021 2020 FY
Q2 2019 $88,605,000 $23,647,000 +$9,116,000 +63% 01 Apr 2019 30 Jun 2019 10-K 24 Feb 2021 2020 FY
Q1 2019 $79,489,000 $28,720,000 +$14,885,000 +108% 01 Jan 2019 31 Mar 2019 10-K 24 Feb 2021 2020 FY
Q4 2018 $64,604,000 $19,957,000 +$3,274,000 +20% 01 Oct 2018 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $61,330,000 $16,281,000 +$2,752,000 +20% 01 Jul 2018 30 Sep 2018 10-K 02 Mar 2020 2019 FY
Q2 2018 $58,578,000 $14,531,000 -$239,000 -1.6% 01 Apr 2018 30 Jun 2018 10-K 02 Mar 2020 2019 FY
Q1 2018 $58,817,000 $13,835,000 +$2,216,000 +19% 01 Jan 2018 31 Mar 2018 10-K 02 Mar 2020 2019 FY
Q4 2017 $56,601,000 $16,683,000 +$4,033,000 +32% 01 Oct 2017 31 Dec 2017 10-K 22 Feb 2019 2018 FY
Q3 2017 $52,568,000 $13,529,000 +$1,370,000 +11% 01 Jul 2017 30 Sep 2017 10-K 22 Feb 2019 2018 FY
Q2 2017 $51,198,000 $14,770,000 +$3,764,000 +34% 01 Apr 2017 30 Jun 2017 10-K 22 Feb 2019 2018 FY
Q1 2017 $47,434,000 $11,619,000 -$234,000 -2% 01 Jan 2017 31 Mar 2017 10-K 22 Feb 2019 2018 FY
Q4 2016 $47,668,000 $12,650,000 +$4,452,000 +54% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 $43,216,000 $12,159,000 +$8,036,000 +195% 01 Jul 2016 30 Sep 2016 10-K 27 Feb 2018 2017 FY
Q2 2016 $35,180,000 $11,006,000 +$8,249,000 +299% 01 Apr 2016 30 Jun 2016 10-K 27 Feb 2018 2017 FY
Q1 2016 $26,931,000 $11,853,000 +$9,584,000 +422% 01 Jan 2016 31 Mar 2016 10-K 27 Feb 2018 2017 FY
Q4 2015 $17,347,000 $8,198,000 01 Oct 2015 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q3 2015 $4,123,000 01 Jul 2015 30 Sep 2015 10-K 23 Feb 2017 2016 FY
Q2 2015 $2,757,000 01 Apr 2015 30 Jun 2015 10-K 23 Feb 2017 2016 FY
Q1 2015 $2,269,000 01 Jan 2015 31 Mar 2015 10-K 23 Feb 2017 2016 FY

HERON THERAPEUTICS, INC. /DE/ Annual Selling and Marketing Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $49,061,000 +$1,976,000 +4.2% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $47,085,000 -$20,558,000 -30% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $67,643,000 -$14,870,000 -18% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $82,513,000 -$4,666,000 -5.4% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $87,179,000 +$23,326,000 +37% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $63,853,000 -$25,911,000 -29% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
2019 $89,764,000 +$25,160,000 +39% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $64,604,000 +$8,003,000 +14% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $56,601,000 +$8,933,000 +19% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $47,668,000 +$30,321,000 +175% 01 Jan 2016 31 Dec 2016 10-K 22 Feb 2019 2018 FY
2015 $17,347,000 +$8,639,000 +99% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $8,708,000 01 Jan 2014 31 Dec 2014 10-K 23 Feb 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.